Crossmark

Peripherally restricted cannabinoid type 1 receptor (CB1R) antagonist, AM6545, potentiates stress-induced hypothalamic–pituitary–adrenal axis activation via a non-CB1R mechanism

Crossref DOI link: https://doi.org/10.1007/s12020-020-02549-1

Published Online: 2020-11-20

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Roberts, Christopher J. https://orcid.org/0000-0003-0889-8567
Hillard, Cecilia J.
License Information

Text and Data Mining valid from 2020-11-20

Version of Record valid from 2020-11-20
More Information

Article History

Received: 1 August 2020

Accepted: 5 November 2020

First Online: 20 November 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below